Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	58.93	-220.82	-537.61
Graham Fair Price	35.77	0.44	0.33
PEG	-76.58	0.27	1.16
Price/Book	-17.97	4.71	5.75
Price/Cash Flow	-85.78	202.90	-1427.23
Prices/Earnings	55.16	-50.50	-112.63
Price/Sales	205.04	30.86	10.12
Price/FCF	-85.78	202.90	-1427.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-98.06	< 0.005	0.06
Operating Margin	-409.83	-0.15	-0.03
ROA	-113.87	< 0.005	< 0.005
ROE	-0.01	-0.02	-82.94
ROIC	< 0.005	-0.02	-102.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.68	-0.41	-65.18
Dividends QOQ	-0.70	-0.14	80.69
EBIT QOQ	0.97	-1.54	58.05
EPS QOQ	0.97	-1.86	91.48
FCF QOQ	-4.71	1.18	-75.02
Revenue QOQ	-0.43	-0.61	-40.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	480.52	1466.69	205.23
Days Sales Outstanding (DSO)	85.55	12.67	-85.19
Inventory Turnover	0.19	0.06	-67.24
Debt/Capitalization	0.43	0.16	-62.56
Quick Ratio	0.27	0.37	38.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	0.61	0.75	22.55
Cash	0.31	0.36	14.58
Capex	< 0.005	< 0.005	-14.68
Free Cash Flow	< 0.005	0.01	479.18
Revenue	0.35	0.09	-73.01
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.15	1.14	-1.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-21.14	-0.30	98.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating